Skeletal findings in the first 12 months following initiation of glucocorticoid therapy for pediatric nephrotic syndrome

Osteoporosis International

Volumn 25, Issue 2, 2014, Pages 627-637

  Phan, V ^a,t   Blydt Hansen, T ^b,x   Feber, J ^c   Alos, N ^a,t   Arora, S ^d,q   Atkinson, S ^d,q   Bell, L ^e,r   Clarson, C ^f   Couch, R ^g,u   Cummings, E A ^h,p   Filler, G ^f   Grant, R M ^i,v   Grimmer, J ^f   Hebert, D ^i,v   Lentle, B ^j,n   Ma, J ^c   Matzinger, M ^c   Midgley, J ^k,m   Pinsk, M ^g,u   Rodd, C ^e,r   Shenouda, N ^c   Stein, R ^f   Stephure, D ^k,m   Taback, S ^b,x   Williams, K ^c   Rauch, F ^e,s   Siminoski, K ^g,u   Ward, Leanne M ^c   Halton, Jacqueline ^c   Jurencak, Roman ^c   Roth, Johannes ^c   Moher, David ^l   Ramsay, Tim ^l   Kloiber, Reinhard ^m   Lewis, Victor ^m   Miettunen, Paivi ^m   Cabral, David ⁿ   Dix, David B ⁿ   Houghton, Kristin ⁿ   Nadel, Helen R ⁿ   Hay, John ^o   Cairney, Elizabeth ^f   Sparrow, Keith ^f   Fernandez, Conrad ^p   Huber, Adam M ^p   Lang, Bianca ^p   O'Brien, Kathy ^p   Barr, Ronald ^q   Coblentz, Craig ^q   Dent, Peter B ^q   Larche, Maggie ^q   Webber, Colin ^q   Abish, Sharon ^r   Scuccimarri, Rosie ^r   Glorieux, Francis ^s   Dubois, Josée ^t   Laverdière, Caroline ^t   Saint Cyr, Claire ^t   Ellsworth, Janet ^u   LeBlanc, Claire ^u   Wilson, Beverly ^u   Charron, Martin ^v   Gaboury, Isabelle ^w   Israels, Sara ^x   Oen, Kiem ^x   Reed, Martin ^x   more..

^a UNIVERSITÉ DE MONTRÉAL   (Canada)

^b UNIVERSITY OF MANITOBA   (Canada)

^c CHILDREN S HOSPITAL OF EASTERN ONTARIO   (Canada)

^d MCMASTER UNIVERSITY   (Canada)

^e MCGILL UNIVERSITY   (Canada)

^f UNIVERSITY OF WESTERN ONTARIO   (Canada)

^g UNIVERSITY OF ALBERTA   (Canada)

^h DALHOUSIE UNIVERSITY   (Canada)

ⁱ UNIVERSITY OF TORONTO   (Canada)

^j UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^k UNIVERSITY OF CALGARY   (Canada)

^l OTTAWA HOSPITAL RESEARCH INSTITUTE   (Canada)

^m ALBERTA CHILDREN'S HOSPITAL   (Canada)

ⁿ BC CHILDREN S HOSPITAL   (Canada)

^o BROCK UNIVERSITY   (Canada)

^p IWK HEALTH CENTRE   (Canada)

^q MCMASTER CHILDREN S HOSPITAL   (Canada)

^r MONTREAL CHILDREN S HOSPITAL   (Canada)

^s SHRINERS HOSPITAL FOR CHILDREN   (Canada)

^t UNIVERSITY OF MONTREAL   (Canada)

^u STOLLERY CHILDREN S HOSPITAL   (Canada)

^v HOSPITAL FOR SICK CHILDREN   (Canada)

^w UNIVERSITÉ DE SHERBROOKE   (Canada)

^x CHILDREN S HOSPITAL RESEARCH INSTITUTE OF MANITOBA   (Canada)

more..

Author keywords

Bone mineral density; Children; Nephrotic syndrome; Osteoporosis; Vertebral fracture

Indexed keywords

GLUCOCORTICOID;

ADOLESCENT; ARTICLE; BONE DENSITY; BONE DEVELOPMENT; CHILD; CHILDHOOD DISEASE; CLINICAL FEATURE; CORTICOSTEROID THERAPY; DUAL ENERGY X RAY ABSORPTIOMETRY; FEMALE; FOLLOW UP; HUMAN; HUMAN TISSUE; INCIDENTAL FINDING; LUMBAR SPINE; MAJOR CLINICAL STUDY; MALE; NEPHROTIC SYNDROME; PHENOTYPE; PRIORITY JOURNAL; SPINE FRACTURE; SPINE RADIOGRAPHY; TREATMENT DURATION; ANTHROPOMETRY; CHEMICALLY INDUCED; CLINICAL TRIAL; DOSE RESPONSE; DRUG EFFECTS; FRAGILITY FRACTURE; INFANT; LUMBAR VERTEBRA; MULTICENTER STUDY; OSTEOPOROSIS; PATHOPHYSIOLOGY; PRESCHOOL CHILD; PROCEDURES;

ADOLESCENT; ANTHROPOMETRY; BONE DENSITY; CHILD; CHILD, PRESCHOOL; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; FOLLOW-UP STUDIES; GLUCOCORTICOIDS; HUMANS; INFANT; LUMBAR VERTEBRAE; MALE; NEPHROTIC SYNDROME; OSTEOPOROSIS; OSTEOPOROTIC FRACTURES; SPINAL FRACTURES;

EID: 84899101601     PISSN: 0937941X     EISSN: 14332965     Source Type: Journal    
DOI: 10.1007/s00198-013-2466-7     Document Type: Article

References (43)

1. Hodson EM, Knight JF, Willis NS, Craig JC (2001) Corticosteroid therapy for nephrotic syndrome in children. Cochrane Database Syst Rev 2
2. Tarshish P, Tobin JN, Bernstein J, Edelmann CM Jr (1997) Prognostic significance of the early course of minimal change nephrotic syndrome: report of the International Study of Kidney Disease in Children. J Am Soc Nephrol 8:769-776
3. Canalis E, Mazziotti G, Giustina A, Bilezikian JP (2007) Glucocorticoid-induced osteoporosis: pathophysiology and therapy. Osteoporos Int 18:1319-1328 (Pubitemid 47389469)
4. Weinstein RS (2012) Glucocorticoid-induced osteoporosis and osteonecrosis. Endocrinol Metab Clin North Am 41:595-611
5. van Staa TP, Cooper C, Leufkens HG, Bishop N (2003) Children and the risk of fractures caused by oral corticosteroids. J Bone Miner Res 18:913-918 (Pubitemid 37294976)
6. Rodd C, Lang B, Ramsay T et al (2012) Incident vertebral fractures among children with rheumatic disorders 12 months after glucocorticoid initiation: a national observational study. Arthritis Care Res 64:122-131
7. Nakhla M, Scuccimarri R, Duffy KN, Chedeville G, Campillo S, Duffy CM, Azouz EM, Shenouda N, Sharma AK, Rodd C (2009) Prevalence of vertebral fractures in children with chronic rheumatic diseases at risk for osteopenia. J Pediatr 154:438-443
8. Varonos S, Ansell BM, Reeve J (1987) Vertebral collapse in juvenile chronic arthritis: its relationship with glucocorticoid therapy. Calcif Tissue Int 41:75-78
9. Feber J, Gaboury I, Ni A et al (2012) Skeletal findings in children recently initiating glucocorticoids for the treatment of nephrotic syndrome. Osteoporos Int 23:751-760
10. Fujita T, Satomura A, Hidaka M, Ohsawa I, Endo M, Ohi H (2000) Acute alteration in bone mineral density and biochemical markers for bone metabolism in nephrotic patients receiving high-dose glucocorticoid and one-cycle etidronate therapy. Calcif Tissue Int 66:195-199 (Pubitemid 30091760)
11. Leonard MB, Feldman HI, Shults J, Zemel BS, Foster BJ, Stallings VA (2004) Long-term, high-dose glucocorticoids and bone mineral content in childhood glucocorticoid-sensitive nephrotic syndrome. N Engl J Med 351:868-875 (Pubitemid 39096913)
12. Sbrocchi AM, Rauch F, Matzinger M, Feber J, Ward LM (2011) Vertebral fractures despite normal spine bonemineral density in a boy with nephrotic syndrome. Pediatr Nephrol 26:139-142
13. Halton J, Gaboury I, Grant R et al (2009) Advanced vertebral fracture among newly diagnosed children with acute lymphoblastic leukemia: results of the Canadian Steroid-Associated Osteoporosis in the Pediatric Population (STOPP) research program. J Bone Miner Res 24:1326-1334
14. International Study of kidney Disease in Children (1981) The primary nephrotic syndrome in children. Identification of patients with minimal change nephrotic syndrome from initial response to prednisone. A report of the International Study of Kidney Disease in Children. J Pediatr 98:561-564
15. Institute of Medicine (1997) Dietary reference intakes for calcium, phosphorus, magnesium, vitamin D, fluoride. National Academy Press, Washington
16. Gbadegesin R, Smoyer WE (2008) Nephrotic syndrome. In: Geary DF, Schaefer F (eds) Comprehensive pediatric nephrology. Elsevier, New York
17. Schwartz GJ, Munoz A, Schneider MF, Mak RH, Kaskel F, Warady BA, Furth SL (2009) New equations to estimate GFR in children with CKD. J Am Soc Nephrol 20:629-637
18. Marshall WA, Tanner JM (1969) Variations in pattern of pubertal changes in girls. Arch Dis Child 44:291-303
19. Marshall WA, Tanner JM (1970) Variations in the pattern of pubertal changes in boys. Arch Dis Child 45:13-23
20. Ogden CL, Kuczmarski RJ, Flegal KM, Mei Z, Guo S, Wei R, Grummer-Strawn LM, Curtin LR, Roche AF, Johnson CL (2002) Centers for Disease Control and Prevention 2000 growth charts for the United States: improvements to the 1977 National Center for Health Statistics version. Pediatrics 109:45-60 (Pubitemid 34049426)
21. World Health Organization Multicentre Growth Reference Study Group (2006) WHO child growth standards: length/height-for-age, weight-for-age, weight-for-length, weight-for-height and body mass index-for-age: methods and development. World Health Organization, Geneva, pp 229-300
22. Musgrave KO, Giambalvo L, Leclerc HL, Cook RA, Rosen CJ (1989) Validation of a quantitative food frequency questionnaire for rapid assessment of dietary calcium intake. J Am Diet Assoc 89:1484-1488 (Pubitemid 19251769)
23. Hay J (1997) Development and validation of the Habitual Activity Estimation Scale (HAES). Children and Exercise XIX II:125-129
24. Wells GD, Wilkes DL, Schneiderman-Walker J, Elmi M, Tullis E, Lands LC, Ratjen F, Coates AL (2008) Reliability and validity of the habitual activity estimation scale (HAES) in patients with cystic fibrosis. Pediatr Pulmonol 43:345-353 (Pubitemid 351544042)
25. van Staa TP, Leufkens HG, Cooper C (2002) The epidemiology of corticosteroid-induced osteoporosis: a meta-analysis. Osteoporos Int 13:777-787 (Pubitemid 36336722)
26. Curtis JR, Westfall AO, Allison J, Bijlsma JW, Freeman A, George V, Kovac SH, Spettell CM, Saag KG (2006) Population-based assessment of adverse events associated with long-term glucocorticoid use. Arthritis Rheum 55:420-426 (Pubitemid 43887028)
27. Dubner SE, Shults J, Baldassano RN, Zemel BS, Thayu M, Burnham JM, Herskovitz RM, Howard KM, Leonard MB (2009) Longitudinal assessment of bone density and structure in an incident cohort of children with Crohn's disease. Gastroenterology 136:123-130
28. Genant HK, Wu CY, van Kuijk C, Nevitt MC (1993) Vertebral fracture assessment using a semiquantitative technique. J Bone Miner Res 8:1137-1148 (Pubitemid 23261108)
29. Keats TE, Smith TH (1977) An atlas of normal developmental anatomy, 2nd edn. Year Book of Medical Publishers, Chicago
30. Gaca AM, Barnhart HX, Bisset GS 3rd (2010) Evaluation of wedging of lower thoracic and upper lumbar vertebral bodies in the pediatric population. AJR Am J Roentgenol 194:516-520
31. Webber CE, Beaumont LF, Morrison J, Sala A, Barr RD (2007) Age-predicted values for lumbar spine, proximal femur, and whole-body bone mineral density: results from a population of normal children aged 3 to 18 years. Can Assoc Radiol J 58:37-45 (Pubitemid 46348495)
32. Newcombe RG (1998) Two-sided confidence intervals for the single proportion: comparison of seven methods. Stat Med 17:857-872
33. Goulding A, Cannan R, Williams SM, Gold EJ, Taylor RW, Lewis-Barned NJ (1998) Bone mineral density in girls with forearm fractures. J Bone Miner Res 13:143-148 (Pubitemid 28063123)
34. Alos N, Grant RM, Ramsay T et al (2012) High incidence of vertebral fractures in children with acute lymphoblastic leukemia 12 months after the initiation of therapy. J Clin Oncol 30:2760-2767
35. Burnham JM (2012) Inflammatory diseases and bone health in children. Curr Opin Rheumatol 24:548-553
36. Bak M, Serdaroglu E, Guclu R (2006) Prophylactic calcium and vitamin D treatments in steroid-treated children with nephrotic syndrome. Pediatr Nephrol 21:350-354 (Pubitemid 43280350)
37. Jia D, O'Brien CA, Stewart SA, Manolagas SC, Weinstein RS (2006) Glucocorticoids act directly on osteoclasts to increase their life span and reduce bone density. Endocrinology 147:5592-5599 (Pubitemid 44833476)
38. Dalle Carbonare L, Bertoldo F, Valenti MT, Zenari S, Zanatta M, Sella S, Giannini S, Cascio VL (2005) Histomorphometric analysis of glucocorticoid- induced osteoporosis. Micron 36:645-652 (Pubitemid 41745029)
39. Gulati S, Sharma RK, Gulati K, Singh U, Srivastava A (2005) Longitudinal follow-up of bone mineral density in children with nephrotic syndrome and the role of calcium and vitamin D supplements. Nephrol Dial Transplant 20:1598-1603 (Pubitemid 41418582)
40. Hegarty J, Mughal MZ, Adams J, Webb NJ (2005) Reduced bone mineral density in adults treated with high-dose corticosteroids for childhood nephrotic syndrome. Kidney Int 68:2304-2309 (Pubitemid 43117808)
41. Wetzsteon RJ, Shults J, Zemel BS, Gupta PU, Burnham JM, Herskovitz RM, Howard KM, Leonard MB (2009) Divergent effects of glucocorticoids on cortical and trabecular compartment BMD in childhood nephrotic syndrome. J Bone Miner Res 24:503-513
42. Tsampalieros A, Gupta P, Denburg MR, Shults J, Zemel BS, Mostoufi-Moab S, Wetzsteon RJ, Herskovitz RM, Whitehead KM, Leonard MB (2013) Glucocorticoid effects on changes in bone mineral density and cortical structure in childhood nephrotic syndrome. J Bone Miner Res 28:480-488
43. Ostalska-Nowicka D, Zachwieja J, Nowicki M, Kaczmarek E, Siwinska A, Witt M (2005) Vascular endothelial growth factor (VEGF-C1)-dependent inflammatory response of podocytes in nephrotic syndrome glomerulopathies in children: an immunohistochemical approach. Histopathology 46:176-183 (Pubitemid 40293016)